Elderly patients with acute myocardial infarction are under-treated despite deriving significant benefit from standard therapies like aspirin, thrombolytics, beta-blockers, and ACE inhibitors.
Answers are grounded in this paper and cite their sources.
Persistent under-treatment in elderly AMI warrants scrutiny; leaves open optimal strategies to boost evidence-based therapy uptake.
Up to half of admissions with myocardial infarction are over 70 years of age. Mortality in this age group is higher than in younger age groups. However, elderly patients are less likely to be managed in an acute coronary care setting. Low dose aspirin should be given to all elderly patients with myocardial infarction. Thrombolytic agents have the greatest effect in the elderly even though they give an increased risk of hemorrhagic stroke. They are underused in the elderly with myocardial infarction for a number of reasons. Ã -Blockers reduce mortality post infarction and ACE inhibitors improve morbidity and mortality rates in those with evidence of heart failure post infarction. Amiodarone may also be of use as an antiarrhythmic in the post infarction period.
No takes yet. Share an insight, caveat, or question.
Reardon et al. (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: